Diaceutics Plc Stock Fundamentals
| DIUXF Stock | USD 1.37 0.00 0.00% |
Fundamental analysis of Diaceutics PLC allows traders to better anticipate movements in Diaceutics PLC's stock price by examining its financial health and performance throughout various phases of its business cycle.
Diaceutics |
Diaceutics PLC Company Operating Margin Analysis
Diaceutics PLC's Operating Margin shows how much operating income a company makes on each dollar of sales. It is one of the profitability indicators which helps analysts to understand whether the firm is successful or not making money from everyday operations.
Current Diaceutics PLC Operating Margin | 0 % |
Most of Diaceutics PLC's fundamental indicators, such as Operating Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Diaceutics PLC is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
A good Operating Margin is required for a company to be able to pay for its fixed costs or payout its debt, which implies that the higher the margin, the better. This ratio is most effective in evaluating the earning potential of a company over time when comparing it against a firm's competitors.
| Competition |
Based on the recorded statements, Diaceutics PLC has an Operating Margin of 0.0012%. This is 100.0% lower than that of the Healthcare sector and 100.0% lower than that of the Diagnostics & Research industry. The operating margin for all United States stocks is 100.02% lower than that of the firm.
Diaceutics PLC Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Diaceutics PLC's current stock value. Our valuation model uses many indicators to compare Diaceutics PLC value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Diaceutics PLC competition to find correlations between indicators driving Diaceutics PLC's intrinsic value. More Info.Diaceutics PLC is one of the top stocks in return on equity category among its peers. It also is one of the top stocks in return on asset category among its peers reporting about 0.09 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Diaceutics PLC is roughly 10.67 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Diaceutics PLC's earnings, one of the primary drivers of an investment's value.Diaceutics Operating Margin Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Diaceutics PLC's direct or indirect competition against its Operating Margin to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Diaceutics PLC could also be used in its relative valuation, which is a method of valuing Diaceutics PLC by comparing valuation metrics of similar companies.Diaceutics PLC is currently under evaluation in operating margin category among its peers.
Diaceutics Fundamentals
| Return On Equity | 0.0032 | |||
| Return On Asset | 3.0E-4 | |||
| Profit Margin | 0.01 % | |||
| Operating Margin | 0 % | |||
| Current Valuation | 54.7 M | |||
| Shares Outstanding | 84.47 M | |||
| Shares Owned By Insiders | 46.89 % | |||
| Shares Owned By Institutions | 47.72 % | |||
| Price To Earning | 112.00 X | |||
| Price To Book | 2.07 X | |||
| Price To Sales | 6.10 X | |||
| Revenue | 13.94 M | |||
| Gross Profit | 10.73 M | |||
| EBITDA | 2.35 M | |||
| Net Income | 561 K | |||
| Cash And Equivalents | 19.68 M | |||
| Cash Per Share | 0.23 X | |||
| Total Debt | 1.56 M | |||
| Debt To Equity | 0.04 % | |||
| Current Ratio | 11.41 X | |||
| Book Value Per Share | 0.49 X | |||
| Cash Flow From Operations | 570 K | |||
| Earnings Per Share | 0.01 X | |||
| Number Of Employees | 133 | |||
| Beta | 0.29 | |||
| Market Capitalization | 94.61 M | |||
| Total Asset | 45.01 M | |||
| Z Score | 36.0 | |||
| Net Asset | 45.01 M |
About Diaceutics PLC Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Diaceutics PLC's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Diaceutics PLC using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Diaceutics PLC based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.Diaceutics PLC, a diagnostic commercialization company, provides data, data analytics, and implementation services for pharmaceutical companies worldwide. Diaceutics PLC was incorporated in 2005 and is headquartered in Belfast, the United Kingdom. Diaceutics Plc is traded on OTC Exchange in the United States.
Currently Active Assets on Macroaxis
Other Information on Investing in Diaceutics Pink Sheet
Diaceutics PLC financial ratios help investors to determine whether Diaceutics Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Diaceutics with respect to the benefits of owning Diaceutics PLC security.